- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03699813
ROTEM Versus aPTT/PT in Pediatric Surgery
Use of Rotational Thromboelastometry (ROTEM) in Pediatric Perioperative Medicine and Its Comparison With Standard Coagulation Tests aPTT/PT
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Pediatric patients who underwent spine surgery (under 18 years old) will be recruited in our study.
Retrospective data will be analysed from these patient who underwent scoliosis surgery before ROTEM implementation to daily practice and after ROTEM implementation do daily practice in our department.
Time to available results of ROTEM versus aPTT/PT tests will be compared. Blood loss and blood products used in these both groups will be analysed and compared between 2 groups.
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
• pediatric patients after surgical correction of scoliosis
Exclusion Criteria:
• patients older than 18 years
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
scoliosis bleeding management based on aPTT/PT
Bleeding and coagulopathy during surgery managed by clinical approach and aPTT/PT tests. Blood loss, consumption of fresh frozen plasma (FFP), red blood cell units consumption and time to aPTT/PT tests result will be analysed. |
|
scoliosis bleeding management based on ROTEM
Bleeding and coagulopathy during surgery managed by ROTEM.
Blood loss, consumption of fresh frozen plasma (FFP), red blood cell units consumption and time to aPTT/PT tests result will be analysed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
analysing blood loss during surgery
Time Frame: 3 years
|
blood loss during scoliosis surgery will analysed in both groups
|
3 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
analysing blood transfusion units consumption
Time Frame: 3 years
|
consumption of blood transfusion products will be analysed in both groups
|
3 years
|
time to results of tests
Time Frame: 3 years
|
time to available results of test ROTEM and aPTT/PT will be analysed and compared between both groups
|
3 years
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 05102018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coagulation Defect; Bleeding
-
HemoSonics LLCEnrolling by invitation
-
HemoSonics LLCCompleted
-
Samsung Medical CenterUnknownPostoperative Hemorrhage | Coagulation Defect; Bleeding | Other Functional Disturbances Following Cardiac SurgeryKorea, Republic of
-
University of SevilleNot yet recruitingNails, Ingrown | Coagulation Defect; Bleeding
-
HemoSonics LLCUniversity Hospital, LilleActive, not recruiting
-
Assiut UniversityCompletedCoagulation Defect; BleedingEgypt
-
Medical University of GrazRecruitingCesarean Section Complications | Hyperfibrinolysis | Coagulation Defect; Bleeding | Peripartum HaemorrhageAustria
-
University of PretoriaWithdrawnDietary Supplements | Bleeding Tendency; Due to Coagulation Defect
-
University Medical Centre LjubljanaUnknownBrain Injuries, Traumatic | Coagulopathy | Coagulation Defect; Bleeding | Coagulation Defect; Acquired | Fibrinolytic Hemorrhage, Acquired
-
Masaryk Hospital Krajská zdravotní a.s.CompletedCoagulation Disorder | Multiple Trauma | Coagulation Defect; Acquired | Coagulation Factor DeficiencyCzechia
Clinical Trials on Comparison of two approaches to bleeding management
-
University of Alabama at BirminghamTerminatedMycoplasma Genitalium InfectionUnited States
-
Multan Medical And Dental CollegeCompleted
-
University of Colorado, DenverRecruitingCardiac Disease | Bleeding PostoperativeUnited States
-
National Center for Gastroentestinal and Liver...Completed
-
Akdeniz UniversityCompleted
-
The Netherlands Cancer InstituteErasmus Medical Center; Amsterdam University Medical Centres (AUMC)Active, not recruitingCRC | Advanced NeoplasiaNetherlands
-
Izmir Dr Suat Seren Chest Diseases and Surgery...Completed
-
Hospital Israelita Albert EinsteinUnknownLiver Cirrhosis | Blood Coagulation Disorders | Evidence of Liver TransplantationBrazil
-
Indiana UniversityCompleted